Cyclacel Pharmaceuticals, Inc.
(NASDAQ : CYCC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.11%176.970.7%$1155.61m
LLYEli Lilly & Co. -0.82%368.941.1%$1059.96m
MRKMerck & Co., Inc. 0.51%110.650.7%$1007.73m
PFEPfizer Inc. 2.59%51.540.9%$959.87m
ABBVAbbVie, Inc. -0.05%165.311.9%$895.08m
BMYBristol-Myers Squibb Co. -0.32%79.671.1%$739.59m
AZNAstraZeneca Plc 0.47%69.171.0%$356.02m
HZNPHorizon Therapeutics Plc 1.34%97.595.4%$290.27m
GSKGSK Plc -0.33%36.760.3%$250.24m
IDXXIDEXX Laboratories, Inc. 1.61%426.873.9%$194.47m
NVSNovartis AG -0.40%91.370.2%$187.74m
ALNYAlnylam Pharmaceuticals, Inc. 2.89%238.018.0%$173.01m
CTLTCatalent, Inc. -4.38%45.151.9%$162.95m
NVONovo Nordisk A/S 1.92%127.640.1%$154.96m
SNYSanofi -1.78%47.090.2%$135.64m

Company Profile

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.